Last updated at 03 Jul 2024 11:40 PM
Director
DIN: 05179319
Sanjay Gajanan Chivate is currently associated with 2 companies in various capacities such as Director and Individual Promoter. They serve as a Director at LIFECARE REMEDIES PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 05179319.Sanjay Gajanan Chivate is currently involved in 2 different roles. Their most recent position is with GREEN AVENUE FARMERS PRODUCER COMPANY LIMITED as a Director. The first company Sanjay Gajanan Chivate was appointed to as a director was LIFECARE REMEDIES PRIVATE LIMITED. Sanjay Gajanan Chivate is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Sanjay Gajanan Chivate is currently associated with 2 companies in various capacities such as Director and Individual Promoter. They serve as a Director at LIFECARE REMEDIES PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 05179319.Sanjay Gajanan Chivate is currently involved in 2 different roles. Their most recent position is with GREEN AVENUE FARMERS PRODUCER COMPANY LIMITED as a Director. The first company Sanjay Gajanan Chivate was appointed to as a director was LIFECARE REMEDIES PRIVATE LIMITED. Sanjay Gajanan Chivate is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
3
Male
India
Gain instant access to verified contact details.
Current Companies (2)
Current LLPs (0)
Past Companies (0)
2y 10m 1y 5m Interval
| Company Name | Designation | Date of Appointment |
|---|---|---|
| LIFECARE REMEDIES PRIVATE LIMITED | Director | 30-Jan-2012 |
| GREEN AVENUE FARMERS PRODUCER COMPANY LIMITED | Director | 25-Feb-2022 |
| GREEN AVENUE FARMERS PRODUCER COMPANY LIMITED | Individual Promoter | 25-Feb-2022 |